The RWD & RWE Podcast

Ep 120 [13 December 2023]: Dan Poscover MBA and Dr. Patrick Hanson – Hola, Ciao, Bon Jour - RWE network building in Europe

Ep 120 [13 December 2023]: Conversation with Dan Poscover MBA, CEO and Co-Founder of Graticule, and Dr. Patrick Hanson, Chief Alliance Officer of Graticule – We discussed the EU lessons learned while establishing am RWE network in Italy, France, and Spain within the context of evidence readiness that aims to meet global needs for studies on immunocompromised patients.

Ep 119 [06 December 2023]: Kathy Belk – The ‘other’ under-represented population: Rural RWD for RWE

Ep 119 [06 December 2023]: Conversation with Kathy Belk, Sr Dir Analytics & Chief Data Scientist for Spacelabs, Co-founder of Elev8Evidence and Founder of Health Clarity Solutions – A great conversation that explored the complexities of healthcare challenges in the rural population, including social drivers of health, access to care, and the often-overlooked nuances impacting rural communities. We discussed how real-world data and data-driven solutions can help provide actionable insight to tackle these challenges head-on.

Ep 118 [29 November 2023]: Mark Shapiro PhD MS MBA – RWD from EHR: Challenges and Opportunities

Ep 118 [29 November 2023]: Conversation with Mark Shapiro PhD MS MBA, Chief Operating Officer (COO) at xCures – We discussed how RWD can be created from electronic health records; in particular, our experience with collection from disparate EHR sources to produce a more complete patient journey, with some of the challenges and risks using disparate EHR sources and to talk about data normalization, privacy concerns and how EHR-derived RWD can benefit patient care and medical research.

Ep 117 [15 November 2023]: Georges De Feu & Shahbaz Pervaiz – Unlock European RWE

Ep 117 [15 November 2023]: Conversation with Georges De Feu, CEO and co-founder of LynxCare – a European RWD provider is joined by his RWE Services Director – Shahbaz Pervaiz – We discussed the need for NLP-AI to unlock European unstructured data and the enablers for federated networks of hospital.

Ep 116 [08 November 2023]: Canter Martin MBA – Selecting the Right RWE/RWD Partner

Ep 116 [08 November 2023]: Conversation with Canter Martin MBA, Executive Leader in Life Science Value & Access and Co-Founder of Elev8Evidence – We discussed the importance of strategic partnerships in the effective use of RWD and generating meaningful RWE -- Best practices in selecting the right partner!

Ep 115 [01 November 2023]: Carla DeMuro MS – RWD - Are we measuring the right thing?

Ep 115 [01 November 2023]: Conversation with Carla DeMuro MS, Vice President, Patient-Centered Outcomes Assessment at RTI Health Solutions – We discussed the use of PROs in real-world evidence generation. Are we measuring the right thing?

Ep 114 [25 October 2023]: Stuart McCully PhD – EU’s RWD Revolution in Health Research & Drug Development

Ep 114 [25 October 2023]: Conversation with Stuart McCully PhD, CEO of RWRegs – We discussed updates on the EU's advancement and global leadership of RWD for RWE.Shared References:- https://www.linkedin.com/posts/stuart-mccully-80a50aa_31-real-world-evidence-rwe-201-eus-activity-7122884522311835648-bUFD/- https://digital-strategy.ec.europa.eu/en/news/european-strategy-data-data-governance-act-becomes-applicable

Ep 113 [18 October 2023]: Mark van der Laan PhD – Get real! Targeted Learning: Why is it Important to Data Analysis?

Ep 113 [18 October 2023]: Conversation with Mark van der Laan PhD, Co-Founder at TL Revolution and Jiann-Ping Hsu/Karl E Peace Professor in Biostatistics and Statistics at UC Berkeley – We had a high-level yet thought-provoking discussion on the importance of using Targeted Learning and Machine Learning to support RWD analysis and clinical research.

Ep 112 [11 October 2023]: Christina Mack PhD – Moment or a movement? Using RWE to impact population health.

Ep 112 [11 October 2023]: Conversation with Christina Mack PhD, Chief Scientific Officer at IQVIA – She shared highlights from her career journey, her passion for where science can take us in a data-driven world, and stories about how real-world evidence is changing the game in professional sports and global public health.

Ep 111 - [04 October 2023]: Sylvia Taylor PhD MPH MBA – COVID-19 vaccines and the pivotal role of RWE

Ep 111 [04 October 2023]: Conversation with Sylvia Taylor PhD MPH MBA, Head of Medical Evidence Strategy, Vaccines & Immune Therapies at AstraZeneca, and a trusted epidemiologist and leader in global health and real-world evidence – We discussed COVID-19 vaccines and the pivotal role of real-world evidence on public health decision making during the pandemic: one epidemiologist’s experience, lessons learned, and thoughts on the future.